Related Experiment Video
Updated: Feb 13, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
Low-Dose Prothrombin Complex Concentrate in Patients with Left Ventricular Assist Devices
Caitlin S Brown1, Wesley R Zemrak2, Kaitlin J Dyer3
1From the Department of Pharmacy, Mayo Clinic, Rochester, Minnesota.
Low-dose 4-factor prothrombin complex concentrate (4F-PCC) effectively reversed warfarin in two left ventricular assist device (LVAD) patients needing urgent procedures. This approach avoided thrombotic complications, suggesting a potential safe strategy for managing bleeding risks in LVAD recipients.
Area of Science:
- Cardiology
- Hematology
- Pharmacology
Background:
- Left ventricular assist devices (LVADs) are crucial for end-stage heart failure but necessitate anticoagulation, increasing bleeding risks.
- Warfarin is commonly used for anticoagulation in LVAD patients, requiring careful management of its reversal.
- Prothrombin complex concentrate (PCC) is used for warfarin reversal, but thrombotic risks exist, particularly in high-risk patients.
Observation:
- Two patients with Heart Mate II LVADs on warfarin required urgent reversal due to bleeding or procedural needs.
- One patient had an INR of 4.7, the other 3.7; both received low-dose 4-factor PCC (4F-PCC).
Findings:
- The first patient received ~16 units/kg of 4F-PCC, achieving INR reversal to 2.3 within 45 minutes.
- The second patient received ~11 units/kg of 4F-PCC, with INR reversal to 1.6 within 1 hour.
- Neither patient experienced thrombotic complications following 4F-PCC administration.
Implications:
- Low-dose 4F-PCC appears to be a safe and effective option for urgent warfarin reversal in LVAD patients.
- This strategy may mitigate bleeding risks without inducing thrombosis in this vulnerable population.
- Further research into optimal low-dose 4F-PCC dosing for LVAD patients is warranted.
Related Concept Videos
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

